Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Valeant

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Valeant's Japan sales performance.

valeant

Takeda agrees $5.2bn deal to buy Ariad

Takeda agrees $5.2bn deal to buy Ariad It is the first major acquisition under Takeda chief executive Christophe Weber since he joined the company from GlaxoSmithKline (GSK) in 2014, after earlier negotiations with Valeant over the sale of

Making a list and checking it twice…

Making a list and checking it twice… Let's start with an obvious one: prices and price increases. The hangover effect of Martin Shkreli and Valeant Pharmaceuticals in 2015 continued to haunt the industry along with new dramas

Valeant's proposed sale of Salix to Takeda 'in jeopardy'

Valeant's proposed sale of Salix to Takeda 'in jeopardy' Xifaxan and Relistor are integral to our gastrointestinal franchise which remains a core asset for future growth potential in the hands of Valeant.". ... hoping Valeant's debt burden would encourage it to do a deal at a knockdown price.

Valeant's ex-CEO and CFO 'could face criminal charges'

Valeant's ex-CEO and CFO 'could face criminal charges' The saga continues at Canadian drugmaker Valeant, with reports emerging that former CEO Michael Pearson and CFO Howard Schiller are under criminal investigation for accounting fraud. ... A Bloomberg report quotes unnamed sources as suggesting that the

EpiDemic

EpiDemic And the next egregious drug-pricing headline is yet to come. But like Valeant and Martin Shkreli before it, the EpiPen narrative teaches us some important lessons.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics